Advanced Therapy Medicinal Products Market

May 2021| MRS237A| Market Research Studies

Report Highlights

The report broadly covers different types of advanced therapy medicinal products based on their therapy type. Furthermore, the scope of the report also covers the impact of COVID-19 and drivers and challenges for Advanced Therapy Medicinal Products market. The report covers the market value for the historic year 2019, followed by the base year 2020, estimated year 2021 and forecast period from 2020 to 2026 for each therapy type, diseases, and regional markets, and the estimated values are derived from the manufacturers’ total revenues.

The report also includes a discussion of the major players across each of the regional advanced therapy medicinal products markets; it explains the major market drivers of the global advanced therapy medicinal products industry, current trends within the industry, major applications, and the regional dynamics of the global advanced therapy medicinal products market.

The report concludes with a special focus on the vendor landscape, which includes detailed profiles of the major vendors in the global advanced therapy medicinal products market.

Report Includes

  • 29 tables and 37 figures
  • An up-to-date analysis of the Global Advanced Therapy Medicinal Products Market.
  • Analyses of the global market trends, with data from 2019, 2020, estimates for 2021, and projections of compound annual growth rates (CAGRs) through 2026.
  • Estimation of market size and revenue forecast for Global Advanced Therapy Medicinal Products Market, and corresponding market share analysis by therapy type, diseases, and region.
  • Highlights of emerging technology trends, gaps and opportunities in the market estimating current and future demand for Advanced Therapy Medicinal Products, identification of the companies that are best positioned to meet this demand.
  • In-depth information (facts and figures) concerning market drivers, restraints and other forces affecting the progress of this market.
  • Identification of promising new products still in the development and testing stages, and their probability of successful commercial launch within the next five years
  • Impact of COVID-19 on the Advanced Therapy Medicinal Products Market as compared to overall global economy.
  • Insight into the growth development strategies of major Advanced Therapy Medicinal Products manufacturers and their key competitive landscape
  • Descriptive company profiles of the leading market participants, including Spark Therapeutics, Inc., bluebird bio, Inc., Novartis International AG, UniQure N.V., Bristol-Myers Squibb Company, Gilead Lifesciences, Inc., Vericel Corporation G, and others.

Summary

Advanced Therapy Medicinal Products (ATMPs) are pioneering treatments that includes tissue engineered products, cell therapy and gene therapy. Cell therapy products consist of cellular immunotherapies and autologous and allogeneic cells for specific medicinal indications including mature and embryonic stem cells. Whereas human gene therapy belongs to products that establish genomic material into people’s DNA to substitute faulty or absent genetic material, thus curing a disease or irregular medical condition.

These are a unique class of drugs that offer potential therapy prospects for diseases that have presently limited or no medicinal options such as metabolic disorders, hemophilia, muscular dystrophies, cystic fibrosis, skin burns, Alzheimer, and even cancer.

Although most of the ATMPs are in an early stage of advancement, established trial stage and the opportunities to cure prolonged conditions signify that ATMPs may accomplish the market sooner than traditional treatments. Furthermore, advanced therapy medicinal products are controlled and certified for marketing by the Food and Drug Administration (FDA) in the U.S. and by European Medicines Agency (EMA) in the Europe.

The Global Advanced Therapy Medicinal Products Market was valued at $7.38 billion in 2020 and is expected to witness a steady growth at a CAGR of 12.43% during the forecast period.

  • Table 1 : Global Advanced Therapy Medicinal Products Market, Through 2026
  • Table 2 : Global Advanced Therapy Medicinal Products Market, by Therapy Type, Through 2026
  • Table 3 : Global Advanced Therapy Medicinal Products Market, by Diseases, Through 2026
  • Table 4 : Global Advanced Therapy Medicinal Products Market, by Region, Through 2026
  • Table 5 : North America Advanced Therapy Medicinal Products Market, by Therapy Type, Through 2026
  • Table 6 : North America Advanced Therapy Medicinal Products Market, by Diseases, Through 2026
  • Table 7 : North America Advanced Therapy Medicinal Products Market, by Country, Through 2026
  • Table 8 : Europe Advanced Therapy Medicinal Products Market, by Therapy Type, Through 2026
  • Table 9 : Europe Advanced Therapy Medicinal Products Market, by Diseases, Through 2026
  • Table 10 : Europe Advanced Therapy Medicinal Products Market, by Country, Through 2026
  • Table 11 : Asia-Pacific Advanced Therapy Medicinal Products Market, by Therapy Type, Through 2026
  • Table 12 : Asia-Pacific Advanced Therapy Medicinal Products Market, by Diseases, Through 2026
  • Table 13 : Asia-Pacific Advanced Therapy Medicinal Products Market, by Country, Through 2026
  • Table 14 : South America Advanced Therapy Medicinal Products Market, by Therapy Type, Through 2026
  • Table 15 : South America Advanced Therapy Medicinal Products Market, by Diseases, Through 2026
  • Table 16 : South America Advanced Therapy Medicinal Products Market, by Country, Through 2026
  • Table 17 : Middle East & Africa Advanced Therapy Medicinal Products Market, by Therapy Type, Through 2026
  • Table 18 : Middle East & Africa Advanced Therapy Medicinal Products Market, by Diseases, Through 2026
  • Table 19 : Middle East & Africa Advanced Therapy Medicinal Products Market, by Country, Through 2026
  • Table 20 : Spark Therapeutics, Inc.: Financial Performance, Through 2020
  • Table 21 : bluebird bio, Inc.: Financial Performance, Through 2020
  • Table 22 : Novartis International AG: Financial Performance, Through 2020
  • Table 23 : UniQure N.V.: Financial Performance, Through 2020
  • Table 24 : Bristol-Myers Squibb Company: Financial Performance, Through 2020
  • Table 25 : Gilead Lifesciences, Inc.: Financial Performance, Through 2020
  • Table 26 : Vericel Corporation: Financial Performance, Through 2020
  • Table 27 : JCR Pharmaceuticals Co., Ltd.: Financial Performance, Through 2020
  • Table 28 : MEDIPOST Co., Ltd.: Financial Performance, Through 2020
  • Table 29 : PHARMICELL Co., Ltd: Financial Performance, Through 2020
  • Figure 1 : Global Advanced Therapy Medicinal Products Market
  • Figure 2 : Global Advanced Therapy Medicinal Products Market, by Value, 2019-2026
  • Figure 3 : Global Advanced Therapy Medicinal Products Market, by Value, by Therapy Type, 2019-2026
  • Figure 4 : Global Advanced Therapy Medicinal Products Market, by Value, by Diseases, 2019-2026
  • Figure 5 : Global Advanced Therapy Medicinal Products Market, by Value, by Region, 2020
  • Figure 6 : Global Advanced Therapy Medicinal Products Market, by Value, by Company, 2020
  • Figure 7 : Global Advanced Therapy Medicinal Products Market, Product Map, 2020
  • Figure 8 : North America Advanced Therapy Medicinal Products Market, by Value, 2019-2026
  • Figure 9 : North America Advanced Therapy Medicinal Products Market, by Value, by Therapy Type, 2019-2026
  • Figure 10 : North America Advanced Therapy Medicinal Products Market, by Value, by Diseases, 2019-2026
  • Figure 11 : North America Advanced Therapy Medicinal Products Market, by Value, by Country, 2020
  • Figure 12 : Europe Advanced Therapy Medicinal Products Market, by Value, 2019-2026
  • Figure 13 : Europe Advanced Therapy Medicinal Products Market, by Value, by Therapy Type, 2019-2026
  • Figure 14 : Europe Advanced Therapy Medicinal Products Market, by Value, by Diseases, 2019-2026
  • Figure 15 : Europe Advanced Therapy Medicinal Products Market, by Value, by Country, 2020
  • Figure 16 : Asia-Pacific Advanced Therapy Medicinal Products Market, by Value, 2019-2026
  • Figure 17 : Asia-Pacific Advanced Therapy Medicinal Products Market, by Value, by Therapy Type, 2019-2026
  • Figure 18 : Asia-Pacific Advanced Therapy Medicinal Products Market, by Value, by Diseases, 2019-2026
  • Figure 19 : Asia-Pacific Advanced Therapy Medicinal Products Market, by Value, by Country, 2020
  • Figure 20 : South America Advanced Therapy Medicinal Products Market, by Value, 2019-2026
  • Figure 21 : South America Advanced Therapy Medicinal Products Market, by Value, by Therapy Type, 2019-2026
  • Figure 22 : South America Advanced Therapy Medicinal Products Market, by Value, by Diseases, 2019-2026
  • Figure 23 : South America Advanced Therapy Medicinal Products Market, by Value, by Country, 2020
  • Figure 24 : Middle East & Africa Advanced Therapy Medicinal Products Market, by Value, 2019-2026
  • Figure 25 : Middle East & Africa Advanced Therapy Medicinal Products Market, by Value, by Therapy Type, 2019-2026
  • Figure 26 : Middle East & Africa Advanced Therapy Medicinal Products Market, by Value, by Diseases, 2019-2026
  • Figure 27 : Middle East & Africa Advanced Therapy Medicinal Products Market, by Value, by Country, 2020
  • Figure 28 : Spark Therapeutics, Inc.: Revenue Share, 2020
  • Figure 29 : bluebird bio, Inc.: Revenue Share, 2020
  • Figure 30 : Novartis International AG: Revenue Share, 2020
  • Figure 31 : UniQure N.V.: Revenue Share, 2020
  • Figure 32 : Bristol-Myers Squibb Company: Revenue Share, 2020
  • Figure 33 : Gilead Lifesciences, Inc.: Revenue Share, 2020
  • Figure 34 : Vericel Corporation: Revenue Share, 2020
  • Figure 35 : JCR Pharmaceuticals Co., Ltd.: Revenue Share, 2020
  • Figure 36 : MEDIPOST Co., Ltd.: Revenue Share, 2020
  • Figure 37 : PHARMICELL Co., Ltd: Revenue Share, 2020

Market Research Studies is a North Carolina based, premier market research company. MRS brings over 50 years of market research publishing experience. Our reports cover a variety of industries such as Healthcare, Chemicals, Materials & Manufacturing, Research & Diagnostics, Environment & Sustainability, among others. Each year MRS releases hundreds of reports covering various topics. These reports are prepared by our in-house of team of Industry expert analysts. We strive to provide in-depth market analysis with accurate data to help our customers make informed decisions.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report